Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Animalcare ( (GB:ANCR) ).
Animalcare Group plc, an international animal health business, announced the exercise of options under its Long Term Incentive Plan, resulting in the issuance of 4,157 new ordinary shares. These shares will be admitted to trading on AIM on June 4, 2025, and will carry the same rights as existing shares, including voting rights. This issuance increases the total number of shares with voting rights to 68,989,072, impacting shareholder calculations under the FCA’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:ANCR) stock is a Buy with a £290.00 price target. To see the full list of analyst forecasts on Animalcare stock, see the GB:ANCR Stock Forecast page.
Spark’s Take on GB:ANCR Stock
According to Spark, TipRanks’ AI Analyst, GB:ANCR is a Outperform.
Animalcare Group shows commendable financial health with effective cost management and strategic acquisitions. Strong technical indicators and attractive valuation bolster its stock appeal. However, rising liabilities and potential overbought technical conditions warrant cautious monitoring.
To see Spark’s full report on GB:ANCR stock, click here.
More about Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven European countries as well as Australia and New Zealand and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
Average Trading Volume: 69,553
Technical Sentiment Signal: Strong Buy
Current Market Cap: £182.1M
Find detailed analytics on ANCR stock on TipRanks’ Stock Analysis page.